as 06-13-2025 4:00pm EST
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
Founded: | 2001 | Country: | Israel |
Employees: | N/A | City: | HAIFA |
Market Cap: | 41.9M | IPO Year: | N/A |
Target Price: | $12.00 | AVG Volume (30 days): | 11.6K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.61 | EPS Growth: | N/A |
52 Week Low/High: | $3.33 - $7.13 | Next Earning Date: | 05-13-2025 |
Revenue: | $1,034,000 | Revenue Growth: | 203.23% |
Revenue Growth (this year): | 472.39% | Revenue Growth (next year): | 254.29% |
PLUR Breaking Stock News: Dive into PLUR Ticker-Specific Updates for Smart Investing
GOBankingRates
15 days ago
GOBankingRates
15 days ago
GOBankingRates
15 days ago
Yahoo Finance
15 days ago
The Guardian
15 days ago
Yahoo Finance Video
15 days ago
Benzinga
15 days ago
Reuters
15 days ago
The information presented on this page, "PLUR Pluri Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.